Lingxiang Jin
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Pharmacology top 10%
-
- Mangiferin and Mango Extracts 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Liver Disease Diagnosis and Treatment 2
- Autophagy in Disease and Therapy 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Circular RNAs in diseases 2
In The Last Decade
Lingxiang Jin
18 papers receiving 512 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 177
- Pharmacology 63
- Complementary and alternative medicine 58
- Toxicology 17
- Hepatology 39
Countries citing papers authored by Lingxiang Jin
This map shows the geographic impact of Lingxiang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiang Jin more than expected).
Fields of papers citing papers by Lingxiang Jin
This network shows the impact of papers produced by Lingxiang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiang Jin. The network helps show where Lingxiang Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingxiang Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2020 | 12 | |
| 3 | 2019 | 10 | |
| 4 | 2019 | 81 | |
| 5 | 2018 | 4 | |
| 6 | 2018 | 36 | |
| 7 | 2018 | 1 | |
| 8 | 2017 | 7 | |
| 9 | 2017 | 9 | |
| 10 | 2017 | 21 | |
| 11 | 2016 | 54 | |
| 12 | 2016 | 9 | |
| 13 | 2016 | 64 | |
| 14 | Neoalbaconol inhibits cell growth of human cholangiocarcinoma cells by up-regulating PTEN. | 2016 | 2 |
| 15 | 2015 | 26 | |
| 16 | 2015 | 95 | |
| 17 | 2015 | 64 | |
| 18 | 2014 | 19 |
About Lingxiang Jin
Lingxiang Jin is a scholar working on Hepatology, Cancer Research and Toxicology, having authored 18 papers that have together received 518 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Mangiferin and Mango Extracts (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Autophagy in Disease and Therapy (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (177 citations), Pharmacology (63 citations) and Complementary and alternative medicine (58 citations). Lingxiang Jin has collaborated with scholars based in China, Spain and France. Frequent co-authors include Chenwei Pan, Zhenzhen Pan, Guangyao Zhou, Wei Lin, Yi Zheng, Peipei Fang, Changlong Xu, Weilai Chen, Jie Li and Yongping Chen. Their work appears in journals such as PLoS ONE, European Journal of Pharmacology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.